Doctors nationwide are still using a gynecological tool months after the U.S. Food and Drug Administration warned that it can spread undetected cancer, demonstrating the limits of the regulator's reach into clinical practice.
Since the FDA warning in April, Johnson & Johnson JNJ +0.60% pulled the device called a laparoscopic power morcellator from the market; many hospitals, such as Boston's Brigham and Women's Hospital and Philadelphia's Temple University Hospital, put moratoriums on the tool; and some regional insurers stopped covering its use.
Still, some gynecologists continue to employ morcellators to remove common benign uterine growths known as fibroids, often in minimally invasive hysterectomies..
Help employers find you! Check out all the jobs and post your resume.
